Clinical Trial Update: A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial of AdAPT-001 in patients with sarcoma and refractory solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chondrosarcoma
• Sarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• AdAPT-001

Snippet

Sponsor: EpicentRx, Inc. | Conditions: Solid Tumor, Adult, Cancer | Phase 2 | Status: RECRUITING